Skip to main content
Gujarat Themis Biosyn Ltd. logo

Gujarat Themis Biosyn Ltd. — Investor Relations & Filings

Ticker · GUJTHEM ISIN · INE942C01045 LEI · 3358009IT99XRO254Q79 BSE.NS Manufacturing
Open in API
Filings indexed 696 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS GUJTHEM

About Gujarat Themis Biosyn Ltd.

https://www.gtbl.in

Gujarat Themis Biosyn Ltd. specializes in the manufacture of active pharmaceutical ingredients and intermediates through advanced fermentation technology. The company focuses on the production of fermentation-based bulk drugs, with a primary product portfolio that includes Rifampicin intermediates and Lovastatin. Utilizing large-scale fermentation processes, the organization engages in strain improvement and media optimization to enhance yield and efficiency. The company operates a dedicated manufacturing facility equipped for complex biotechnological processes. Through technical collaborations with international entities, it has integrated specialized expertise in fermentation science to support the development of high-purity chemical compounds. Its operations are centered on providing essential building blocks for various therapeutic applications, maintaining a focus on technical precision and process-driven manufacturing excellence.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 30 of SEBI (LODR)
Regulatory Filings Classification · 80% confidence The document is a stock exchange disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regarding the incorporation of a wholly-owned subsidiary in Japan. It is a routine regulatory announcement rather than a financial report, earnings release, share issuance, M&A transaction, or other specialized category. Therefore, it falls under General Regulatory Filings (fallback category).
2026-05-20 English
General Updates
Regulatory Filings Classification · 85% confidence The document is a regulatory compliance disclosure under SEBI LODR Reg. 30 announcing the incorporation of a wholly owned subsidiary in Japan. It is not an actual financial report, not a dividend, not a share issue by the parent, nor a merger/takeover. It’s a routine listing regulation filing. This fits the fallback category of Regulatory Filings (RNS).
2026-05-19 English
Please refer to our intimation under reg 30 of SEBI (LODR) Regulations, 2015 w.r.t. incorporation of wholly owned subsidiary in Japan.
Regulatory Filings Classification · 78% confidence The document is an official disclosure filed under SEBI Listing Regulations (Regulation 30) to the BSE/NSE regarding the incorporation of a wholly-owned subsidiary in Japan. It is a routine regulatory/compliance announcement of a corporate action, not an annual or interim financial report, not a management or board change, not an M&A takeover or share issue by the listed entity. Thus, it falls into the general regulatory filings category (RNS) as a fallback for compliance disclosures that do not fit other specific categories.
2026-05-19 English
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve audited financial results ....
Regulatory Filings Classification · 85% confidence The document is a formal notice under SEBI Listing Regulations informing stock exchanges of the date of the Company’s Board meeting to consider and approve audited financial results and recommend dividends. It does not itself contain financial data or results, nor does it announce changes in directors or senior management. It is a regulatory announcement to the exchanges, fitting the general “Regulatory Filings” category (RNS) as a fallback for miscellaneous compliance disclosures.
2026-05-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter dated 6th May 2026 from Gujarat Themis Biosyn Limited addressed to stock exchanges (BSE and NSE) regarding the publication of a Notice of Postal Ballot in newspapers, pursuant to SEBI Listing Regulations. It includes a statement that the notice has been published in newspapers and attaches copies of the newspaper articles. The content is an announcement about the publication of a notice related to shareholder voting, not the notice itself or the results of the voting. The document is approximately 11,105 characters, which is relatively short and primarily serves as a regulatory announcement. There is no detailed financial data, management discussion, or voting results included. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about the publication of a notice, not the notice itself or the voting results.
2026-05-06 English
Please refer to the copy of Newspaper Publication of Postal Ballot Notice.
Regulatory Filings Classification · 90% confidence The document is an official notification to the stock exchanges under SEBI Listing Regulations about the publication of a newspaper advertisement for a postal ballot notice. It does not contain financial statements, voting results, or detailed proxy materials themselves but is a compliance announcement under listing obligations. This fits the “Regulatory Filings” (RNS) category as a general regulatory announcement.
2026-05-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.